Sarcoma Kaposi

• EMA withdrawal · 2020-07-27
  EMA Application withdrawn: Doxorubicin Hydrochloride Tillomed (doxorubicin hydrochloride) — Laboratorios Tillomed Spain S.L.U

  The EMA withdrew the application for doxorubicin hydrochloride from Laboratorios Tillomed Spain S.L.U. for several cancer indications includ…

• EMA withdrawal · 2010-03-22
  EMA Withdrawn: Paxene (paclitaxel) — Norton Healthcare Ltd.

  Paxene (paclitaxel) is withdrawn from consideration by Norton Healthcare Ltd., affecting indications including sarcoma (Kaposi), non-small c…